Company intelligence / Profile preview

IPMC

Ownership: Private
Development stage: Phase 2

Overview

IPMC operates as a global hub for precision and personalized medicine with a strong focus on cell therapy, genomics-driven diagnostics/treatments, and international collaboration. Its lead partnered program KDS2010—a novel oral inhibitor of aberrant GABA production—is entering Phase 2 trials targeting obesity and neurodegenerative diseases such as Alzheimer's disease. The organization also supports stem cell banking, NIPT testing, cohort studies by race/gender/age diversity, neonatal gene analysis, and more. It aims to set new standards in future modern medicine through its platform approach.

Therapeutic areas: OncologyEndocrinologyNeurology
Modalities: Small moleculesCell therapies/stem cell therapiesGenomics-based personalized medicine
Industry: Biotech

Drug pipeline

1 asset

KDS2010

Phase 2

Indications: Obesity, Alzheimer's disease

Partnerships

Scilex Holding Company—joint venture to develop/commercialize KDS2010 globallyBio Open Innovation Consortium (BOIC)

Beyond the preview

Go deeper on IPMC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IPMC.

Explore the full profile